Presentation TCT 2023 We Need More Data: Unanswered Questions, Current and Future Trials Presenter: Jeffrey Moses October 24, 2023
Presentation TCT 2023 The Future of Transcatheter Therapies for AR: The Impact of the ALIGN-AR Trial Presenter: Martin Leon October 24, 2023
News Conference News TCT 2023 WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone Todd Neale October 24, 2023
Presentation TCT 2023 The Future of Clinical Data for The Reducer Presenter: Megha Prasad October 24, 2023
News Conference News TCT 2022 Calcified Nodules Signal Worst Outcome Among OCT-Defined ACS Causes Todd Neale September 22, 2022
News Conference News TCT 2022 RIVARAD: Rivaroxaban a Possible Solution to Radial Artery Occlusion Todd Neale September 21, 2022
News Conference News TCT 2022 SCAAR Registry Delves Into Left Main Revascularization Outcomes Michael O'Riordan September 19, 2022
News Conference News TCT 2022 Ultrasound for Femoral Access? Neutral Results vs Common Sense: UNIVERSAL Yael L. Maxwell September 19, 2022
News Conference News TCT 2022 RADIANCE II Confirms Ultrasound-Based Renal Denervation Lowers BP Todd Neale September 18, 2022
Presentation TCT 2022 Influential Trials in High-Risk PCI: Shaping the Future of Ischemic Heart Failure Therapy Presenter: Jonathan Hill September 18, 2022
News Conference News TCT 2022 Pulmonary Artery Denervation in Idiopathic PAH Ups 6-Minute Walk Test Shelley Wood September 18, 2022
Presentation TCT 2022 The Future of Sirolimus Coated Balloons: a look at the design of IDE clinical trials Presenter: Azeem Latib September 18, 2022
Presentation TCT 2022 Ongoing Clinical Trials and the Future of LAAC Presenter: Matthew Price September 18, 2022
Presentation TCT 2022 Update on the RADIANCE Clinical Trials Program (Ultra-Sound Renal Denervation) Presenter: Naomi Fisher September 17, 2022
Presentation TCT 2022 Update on the SPYRAL Clinical Trials Program (Radiofrequency Renal Denervation) Presenter: David Kandzari September 17, 2022
Presentation TCT 2022 Expanding the Boundaries of MR Treatments with Early Results from the SUMMIT Trial Presenter: Gorav Ailawadi September 17, 2022
Presentation TCT 2022 5-Year RESTORE SVD China Trial: Restore DCB vs. DES Resolute Integrity in SVD Presenter: ShaoLiang Chen September 17, 2022
Presentation TCT 2022 3-Year Outcome of paclitaxel DCB vs. DES for Native Vessel Disease Treatment: Final Follow Up of the Randomized PICCOLETO II Trial Presenter: Bernardo Cortese September 17, 2022
News Conference News TCT 2022 TAVI Sees Rapid Growth for Severe AS Across Age Spectrum in US Caitlin E. Cox September 16, 2022
News Conference News TCT 2022 Primordial Prevention Before End-stage CVD: Experts Call for a Fresh Focus Yael L. Maxwell September 16, 2022